Robin Kral
Corporate Officer/Principal chez REATA PHARMACEUTICALS, INC.
Postes actifs de Robin Kral
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| REATA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2004 | - |
Historique de carrière de Robin Kral
Anciens postes connus de Robin Kral
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | - | - |
| NPS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Formation de Robin Kral
| Texas Tech University | Graduate Degree |
| David Eccles School of Business | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
- Bourse
- Insiders
- Robin Kral
- Expérience
